
    
      16 weeks. It is planned that this study will be conducted at a single site and will enroll
      approximately 40 subjects over 2-4 months. At the end of the 12-week dosing period, the study
      drug will be discontinued and all subjects in the treatment groups and control group will be
      followed for an additional 4 weeks.
    
  